Esperante is a corporate venture investment company focussed on investing in mid to late stage clinical stage therapeutics development companies in North America and Europe. Esperante is part of C&P Investors Group, a pharmaceutical group of companies engaged in the development, manufacturing, marketing and sales of diagnostic, ophthalmic, pharmaceutical and peptide-based products and services.
Therapeutic fields of interest
Endocrinology
Hepatology
Ophthalmology
Gastroenterology
Infectious disease
Otology
Gynaecology
Oncology
Urology
